Variant report
Variant | nsv548098 |
---|---|
Chromosome Location | chr1:166595209-166623180 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:12)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:166598318..166601316-chr1:166603442..166605798,2 | K562 | blood: | |
2 | chr1:166598376..166600400-chr1:166600678..166602405,2 | K562 | blood: | |
3 | chr1:166606674..166608700-chr1:166627422..166629735,2 | MCF-7 | breast: | |
4 | chr1:166598376..166600400-chr1:166600678..166602405,2 | K562 | blood: | |
5 | chr1:166599816..166602307-chr1:166602461..166604942,2 | K562 | blood: | |
6 | chr1:166589682..166592157-chr1:166593940..166597259,3 | K562 | blood: | |
7 | chr1:166592488..166594055-chr1:166594735..166596268,2 | K562 | blood: | |
8 | chr1:166584740..166586661-chr1:166593653..166596420,2 | K562 | blood: | |
9 | chr1:166599816..166602307-chr1:166602461..166604942,2 | K562 | blood: | |
10 | chr1:166598318..166601316-chr1:166603442..166605798,2 | K562 | blood: | |
11 | chr1:166598296..166600144-chr1:166632730..166634319,2 | K562 | blood: | |
12 | chr1:166563481..166565697-chr1:166594929..166597318,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs714339 | chr1:166595209-166595210 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs377392285 | chr1:166595223-166595224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185972934 | chr1:166595229-166595230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567070309 | chr1:166595258-166595259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201133303 | chr1:166595261-166595262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148940791 | chr1:166595301-166595302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527740138 | chr1:166595302-166595303 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147033049 | chr1:166595356-166595357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78493202 | chr1:166595358-166595359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138422037 | chr1:166595470-166595471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547508852 | chr1:166595487-166595488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12132853 | chr1:166595565-166595566 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs192017174 | chr1:166595579-166595580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562243844 | chr1:166595588-166595589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183968744 | chr1:166595637-166595638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143899948 | chr1:166595653-166595654 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534132869 | chr1:166595655-166595656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs145988498 | chr1:166595666-166595667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148236612 | chr1:166595676-166595677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188563555 | chr1:166595689-166595690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1631056 | chr1:166595692-166595693 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs570246891 | chr1:166595703-166595704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565820589 | chr1:166595708-166595709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536184502 | chr1:166595747-166595748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141354804 | chr1:166595803-166595804 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535645862 | chr1:166595807-166595808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192049335 | chr1:166595829-166595830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577379947 | chr1:166595840-166595841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543121861 | chr1:166595864-166595865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555020500 | chr1:166595883-166595884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150810629 | chr1:166595893-166595894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542251472 | chr1:166595908-166595909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139194711 | chr1:166595943-166595944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527971100 | chr1:166596042-166596043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541719094 | chr1:166596074-166596075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10918539 | chr1:166596081-166596082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565376 | chr1:166596083-166596084 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs182736186 | chr1:166596119-166596120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140739623 | chr1:166596126-166596127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374151332 | chr1:166596127-166596128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201685068 | chr1:166596143-166596144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199632361 | chr1:166596144-166596145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200511434 | chr1:166596145-166596146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201300665 | chr1:166596146-166596147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550252457 | chr1:166596149-166596150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs199803863 | chr1:166596152-166596153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200609943 | chr1:166596153-166596154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201686325 | chr1:166596154-166596155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs199898957 | chr1:166596155-166596156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs201260702 | chr1:166596156-166596157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:166595000-166596000 | Enhancers | K562 | blood |
2 | chr1:166595200-166596000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr1:166596000-166601600 | Weak transcription | K562 | blood |
4 | chr1:166601600-166602600 | Enhancers | K562 | blood |
5 | chr1:166607200-166607800 | Enhancers | Esophagus | oesophagus |
6 | chr1:166607800-166608000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |